Send us Fan Mail

Heart Health Month provides the backdrop for a timely discussion on the latest breakthroughs in treating cardiovascular disease. This is a rebroadcast of Dr. Michael Koren and Dr. Victoria Helow's examination of the sobering reality of heart disease statistics, the impact of statins, and the promising PCSK9 inhibitors on the horizon. We'll provide you with a snapshot of what you need to know about lowering dangerous LDL levels and the accessibility of cutting-edge treatments. By comparing the effects of lifestyle changes and medical interventions, we give you a well-rounded perspective on how to approach heart disease management.

Rounding off our episode, we're on the cusp of a revolution in heart disease prevention with a semi-annual injectable targeting PCSK9. We're excited to discuss the prospects of this game-changing treatment, designed to offer long-term protection against high LDL cholesterol. The anticipation builds as we prepare to bring you the latest findings from the American College of Cardiology meeting in Atlanta. So stay with us, and together let's navigate the future of cardiovascular care, keeping you informed and heart-healthy for years to come.

Talking Tips to Share:

• Understanding Lipid Issues and Cholesterol Numbers
• Understanding Lipoproteins and LDL Levels
• Breakthroughs in Heart Disease Treatment
• Cholesterol, Lipoproteins, and Heart Health
• Injectable PCS-K9 Vaccine Study Presentation

Recording Date: February 21, 2024

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!